Holen Sie sich die Stockscreener-App
0.1515
3.81%
-0.006
Finanzdaten der Arcadia Biosciences Inc-Aktie (RKDA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
31.18%
1.443
|
1.10 | 0.901 | 1.302 | 1.455 |
| Cost Of Revenue |
16.00%
0.812
|
0.70 | 0.709 | 0.884 | 0.824 |
Selling, General, and Administrative
|
4.41%
1.127
|
1.179 | 1.567 | - | 2.123 |
| Costs And Expenses |
3.19%
1.939
|
1.879 | 2.276 | 2.454 | 1.956 |
| Operating Income/Loss |
36.33%
-0.496
|
-0.779 | -1.375 | -1.152 | -0.501 |
| Net Interest Income/Expense |
60.00%
0.002
|
0.005 | -0.001 | 0.007 | 0.009 |
| Net Income/Loss |
42.90%
-6.266
|
-4.385 | -1.336 | 0.856 | -4.458 |
| Basic Average Shares |
43.67%
2.9926
|
2.0829 | - | 1.3672 | 1.367 |
| Diluted Average Shares |
43.67%
2.9926
|
2.0829 | - | 1.3719 | 1.367 |
| Basic Earnings Per Share |
0.95%
-2.09
|
-2.11 | - | 0.63 | -3.26 |
| Diluted Earnings Per Share |
0.95%
-2.09
|
-2.11 | - | 0.62 | -3.26 |
1.01%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):